Can Lipofuscin Deposition on Renal Allograft Tubular Epithelium Be a Surrogate Marker for Kidney Allograft Aging?


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 23 12 2018
revised: 02 03 2019
accepted: 13 03 2019
pubmed: 12 5 2019
medline: 6 7 2019
entrez: 12 5 2019
Statut: ppublish

Résumé

Lipofuscin is an indicator of aging. We examined the clinicopathologic significance of lipofuscin deposition in the renal tubules of renal allografts. We analyzed allograft biopsy specimens from living kidney transplantations from January to December 2015. For controls, we analyzed native kidney biopsy specimens obtained from January 2015 to December 2016. We identified granules with a yellow-to-tan shade in renal tubules as lipofuscin. The donor age at transplantation was significantly older in lipofuscin deposition biopsy specimens than in those without, whereas the time after transplantation age was not different between the 2 groups with renal allografts. In native kidney biopsies, age at biopsy was significantly older in lipofuscin deposition biopsy specimens than in those without. We compared "massive lipofuscin deposition," defined as lipofuscin deposition on both sides of 3 or more renal tubules, and donor-age matched control allograft biopsies without lipofuscin deposition. Comparing these 2 groups, recipient age at transplantation was significantly older in the massive lipofuscin deposition group. Lipofuscin deposition on tubular epithelium is not a surrogate marker of aging of kidneys allografts, although lipofuscin deposition was significantly greater in older tissues from native kidneys. The older age of recipients may be associated with massive lipofuscin deposition in renal allografts.

Sections du résumé

BACKGROUND BACKGROUND
Lipofuscin is an indicator of aging. We examined the clinicopathologic significance of lipofuscin deposition in the renal tubules of renal allografts.
METHOD METHODS
We analyzed allograft biopsy specimens from living kidney transplantations from January to December 2015. For controls, we analyzed native kidney biopsy specimens obtained from January 2015 to December 2016. We identified granules with a yellow-to-tan shade in renal tubules as lipofuscin.
RESULTS RESULTS
The donor age at transplantation was significantly older in lipofuscin deposition biopsy specimens than in those without, whereas the time after transplantation age was not different between the 2 groups with renal allografts. In native kidney biopsies, age at biopsy was significantly older in lipofuscin deposition biopsy specimens than in those without. We compared "massive lipofuscin deposition," defined as lipofuscin deposition on both sides of 3 or more renal tubules, and donor-age matched control allograft biopsies without lipofuscin deposition. Comparing these 2 groups, recipient age at transplantation was significantly older in the massive lipofuscin deposition group.
CONCLUSION CONCLUSIONS
Lipofuscin deposition on tubular epithelium is not a surrogate marker of aging of kidneys allografts, although lipofuscin deposition was significantly greater in older tissues from native kidneys. The older age of recipients may be associated with massive lipofuscin deposition in renal allografts.

Identifiants

pubmed: 31076149
pii: S0041-1345(18)31830-X
doi: 10.1016/j.transproceed.2019.03.017
pii:
doi:

Substances chimiques

Biomarkers 0
Lipofuscin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1343-1347

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Yuki Kawaguchi (Y)

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Hideyo Oguchi (H)

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan. Electronic address: 302211oh@med.toho-u.ac.jp.

Tetuo Mikami (T)

Department of Pathology, Toho University Faculty of Medicine, Tokyo, Japan.

Yutaka Yamaguchi (Y)

Yamaguchi's Pathology Laboratory, Chiba, Japan.

Yasushi Ohashi (Y)

Department of Nephrology, Sakura Medical Center, Toho University, Chiba, Japan.

Takeshi Kawamura (T)

Department of Nephrology, Sakura Medical Center, Toho University, Chiba, Japan.

Masaki Muramatsu (M)

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Yoshihiro Itabashi (Y)

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Kazunobu Shinoda (K)

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Yoji Hyodo (Y)

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Yusuke Takahashi (Y)

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Hiroka Onishi (H)

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Taichi Arai (T)

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Yuko Hamasaki (Y)

Department of Pediatric Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Kazutoshi Shibuya (K)

Department of Surgical Pathology, Toho University Faculty of Medicine, Tokyo, Japan.

Seiichiro Shishido (S)

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Ken Sakai (K)

Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH